Namibia starts administration of Pfizer/BioNTech COVID-19 vaccines to children

WINDHOEK, Dec. 7 — Namibia’s executive director of Health and Social Services Ben Nangombe said on Monday that Namibia has decided to expand its vaccination eligibility to children and adolescents aged 12 to 17 years, following the World Health Organization’s recommendation that the Pfizer/BioNTech COVID-19 vaccine is suitable for use by persons aged 12 years.
“The vaccine is administered in two doses. Each dose is 0.3 ml. The second dose is given 21 days after the first dose. The vaccine is available and is being offered at all vaccination sites across the country,” he said in a notification.
Nangombe said informed consent for vaccination of children aged 12 to 13 years shall be obtained from parents or guardians who opt to have their children vaccinated, while adolescents aged 14 to17 years, will give consent for themselves.
“Children and adolescents falling under the aforementioned age group, and their families, are encouraged to visit vaccination sites across the country to get vaccinated,” he said. (Xinhua)